Purchase Order 75D30122P14547
Award Date
7/14/22
Potential Completion Date
7/23/22
Potential Value
$90K
Federal Agency
CDC Pittsburgh
Awardee
Roche Diagnostics Corporation
Ultimate Awardee
Not listed
NAICS Category
339112 - Surgical and Medical Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46250, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the delivery of MAGNA PURE 96 INSTRUMENTS. The contract, which has a potential value of $180,000.00, does not have a set-aside designation and has an anticipated completion date of April 15, 2022. Roche Diagnostics, a foreign-owned, for-profit manufacturer of in vitro diagnostics,...
This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the MAGNA PURE 96 INSTRUMENT IVD, with a ceiling value of $90,000.00 and a completion date of July 15, 2017. Roche Diagnostics has received numerous federal contract awards, including through its...
This is a $97,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the acquisition of MAGNA PURE EQUIPMENT and does not have a set-aside designation. Roche Diagnostics has received multiple prime contract and subcontract awards from various federal agencies to provide...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for ROCHE MAGNA PURE 96 laboratory equipment. The contract has a ceiling value of $90,000.00 and a completion date of September 29, 2022. Roche Diagnostics has experience as a prime contractor and subcontractor providing medical equipment, reagents, and associated products and services to various federal agencies, including the Department of Veterans Affairs,...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the MAGNA PURE96 INSTRUMENT. The contract has a ceiling value of $91,563.00 and an ultimate completion date of August 31, 2017. The contract is not designated as a set-aside. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to...
This is a $97,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The contract, titled "MAGNA 96", has an ultimate completion date of November 30, 2015 and does not have a set-aside designation. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment,...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Roche Diagnostics Corporation for the MAGNA PURE 96 IVD INSTRUMENT. The contract has a ceiling value of $105,000.00 and an ultimate completion date of March 21, 2016. The contract is not designated as a set-aside. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated...
This $52,252 firm fixed price purchase order contract was awarded to Roche Diagnostics Corporation by the Centers for Disease Control and Prevention (CDC) on September 2, 2022. The contract is for MAGNAPURE 24, a diagnostic product, with a performance period ending on August 24, 2023. Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is a manufacturer and distributor of in vitro diagnostic products, laboratory instruments, and associated medical supplies. This contract...
This is a $97,000 firm fixed-price purchase order contract awarded by the Medical Command of the U.S. Department of Defense to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the MAGNA PURE 96 SYSTEM, with a completion date of December 11, 2020. This contract was awarded without a set-aside designation and is part of the federal government's National Interest...
This federal contract award, with an ID of HHSD2002017M93189P, was made by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for the procurement of a MAGNA PURE 96 INSTRUMENT WITH ACCESSORIES. The fixed-price contract has a ceiling value of $105,000.00 and an ultimate completion date of March 30, 2017. Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory...